drugset / Trial / NCT01498380

The Bolus Dose of Dexmedetomidine (ED50) That Avoids Hemodynamic Compromise in Children

NCT01498380 ↗

Completed 21 enrolled University of British Columbia
NaSingle-groupOpen-labelTreatment

Summary

Dexmedetomidine is a sedative drug that has many benefits when given to children under anesthesia, such as improved pain relief and reduced agitation following their surgery. It is usually given as an intravenous infusion over 10 minutes, to avoid the changes in heart rate and blood pressure that are occasionally seen when it is administered more quickly. However, this is often infeasible and usually inconvenient. The investigators aim to determine the dose of dexmedetomidine that can be given rapidly (over 5 seconds) without causing significant changes in heart rate and blood pressure. This will be the only study specific intervention.

Timeline

Start
2012-01
Primary completion
2013-09
Completion
2013-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.25 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 2 ug/kg Intravenous

Indications

No indication recorded.